Zafer Yalım

Zafer Yalım

Auto-generated profile, based on publicly available information

Zafer Yalım

Department of Cardiology, Afyonkarahisar Health Science University, Afyonkarahisar, Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2023 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Closed access
ZYZafer Yalım
Zafer Yalım
SOSerap Tutgun Onrat
Serap Tutgun Onrat
IDIbrahim Etem Dural
Ibrahim Etem Dural
EOErsel Onrat
Ersel Onrat
Background: Coronary artery ectasia (CAE), known for localized or diffuse excessive dilatation of the coronary artery, has an unknown etiology, but it has been reported that the underlying cause may be atherosclerosis and genetic changes that may affect the arterial lumen. MicroRNAs have been shown to have an effect in aneurysm diseases and are known to contribute to vascular development and atherosclerosis. The purpose of this study was to investigate whether they are also associated with CAE. Methods: This cross-sectional study consisted of 25 patients with CAE and 25 subjects with normal coronary arteries. Blood was collected and miRNA expression was detected using the Rotor-GeneQ real-time polymerase chain reaction cycler (Qiagen) to investigate expression levels of miR-24-1-5p, miR-34a-5p, miR-126-5p, miR-143-5p, and miR-145-5p. Results: Demographic variables of CAE (mean age 59.5 ± 1.7; 12 women) and controls (mean age 57.2 ± 2.1; 16 women) were similar. miR-126-5p ( p = 0.014) and miR-145-5p ( p = 0.003) levels were found to be <2-fold upregulated in CAE compared to controls; miR-143-5p also showed upregulation, but it was not significant ( p = 0.078). Conversely, miR-24-1-5p ( p = 0.032) levels were downregulated in CAE compared to controls. miR-34a-5p was also downregulated, but this was not considered significant ( p = 0.185). Conclusions: According to our study findings, miR-126-5p, miR-145-5p , and miR-24-1-5p may be associated with CAE. These microRNAs could be of diagnostic and therapeutic significance for further studies of CAE involving abnormal angiogenesis and vascular disorders and potentially serve as useful biomarkers.

29 October 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
SOSerap Tutgun Onrat
Serap Tutgun Onrat
IDİbRahim Etem Dural
İbRahim Etem Dural
ZYZafer Yalım
Zafer Yalım
EOErsel Onrat
Ersel Onrat

23 November 2021 in Archivos de Cardiología de México
Verified
Journal Article
Open access
ZYZafer Yalim
Zafer Yalim
ÍEÍbrahim Ersoy
Íbrahim Ersoy
Objective: Mitral valve prolapse (MVP) is the most common cause of mitral regurgitation in developed countries. The role of inflammation in the pathogenesis of MVP is still not clear. In this study, we aimed to investigate how inflammatory markers such as monocyte/high-density lipoprotein ratio (MHR), lymphocyte/monocyte ratio (LMR), neutrophil/lymphocyte ratio (NLR), and platelet/neutrophil ratio (PLR) are affected in MVP patients. Methods: In this retrospective study, we included 461 patients with MVP and 459 normal echocardiographic patients, matched with gender and age. Inflammatory markers and all variables were compared between the two groups. Results: There were no statistically significant differences in age, sex, or body mass index between the two groups. Neutrophil counts (4,960 [3,900-6,780]. 4,200 [3,800-5,600], p < 0.001), NLR (2.488 [1.72-4.51], 1.857 [1.49-2.38], p < 0.001), MHR (14.9 [11.9-18.6], 12.2 [9.4-17.3], p = 0.003), PLR (122.4 [85-171], 104.4 [85-130], p < 0.001), and CRP (0.71 +/- 0.50, 0.67 +/- 0.33 p < 0.001) were significantly higher, and LMR ( 3.75 [2.75-5.09], 4.06 [3.12-4.83] p = 0.016) was significantly lower in the MVP group than the control group, respectively. In logistic regression analysis, NLR (odds ratio [OR]: 1.058 [1.047-1.072]; p < 0.001), LMR (OR: 1.560 [1.211-2.522]; p = 0.027), and PLR (OR: 1.015 [1.012-1.019]; p = 0.003) were found to be independent predictors for MVP presence. Conclusions: These parameters can be used as a simple, low-cost, practical tool to detect inflammation in MVP.

1 December 2020 in International Angiology
Verified
Journal Article
Closed access
ZYZafer Yalim
Zafer Yalim
MAMustafa Aldemir
Mustafa Aldemir
SYSümeyra Alan Yalim
Sümeyra Alan Yalim
Background: The CHA(2)DS(2)-VASc (congestive heart failure, hypertension, age >75 years, diabetes mellitus, previous stroke, vascular disease, age 65-74 years, female gender) score is used to estimate thromboembolic risk in atrial fibrillation (AF). Current studies have shown that CHA(2)DS(2)-VASc score can predict adverse clinical outcomes in coronary artery disease, stroke, and many diseases irrespective of the presence of AF. The usefulness of CHA(2)DS(2)-VASc score in predicting mortality of peripheral arterial disease (PAD) patients is unknown. In this study, we aimed to evaluate the predictive value of the CHA(2)DS(2)-VASc score for mortality of PAD patients. Methods: A total of 396 patients diagnosed with PAD for the first time in our clinic between January 2010-July 2016 were included in this study. Patients were divided into two groups as deceased (group 1, N.=153) and living (group 2, N.=243). A ROC analysis was performed to determine if CHA(2)DS(2)VASc score could predict the death events among PAD patients. Kaplan-Meier analysis was used to evaluate the timing of death events in the two groups. Results: The mean ages of group 1 and group 2 were 76.6 +/- 0.81 and 66.50.83 (P=0.007), respectively. The CHA(2)DS(2)VASc scores of group-1 (4.37 +/- 0.1) and group 2 (2.96 +/- 0.9) were significantly different (P<0.001). A significant correlation between CHA(2)DS(2)VASc score and death was determined in Spearman correlation (R:0.454, P<0.001). According to multivariate cox regression analysis, CHA(2)DS(2)-VASc score [odds ratio (OR): 1.81 (95% CI: 1.42-2.30); P<0.0011, Stroke [OR: 0.43 (95% Cl: 0.21-0.85); P=0.016] and CRP [OR: 1.04 (95% CI: 1.01-1.06); P=0.0021 were independent predictors of death. Conclusions: The CHA(2)DS(2)VASc score is directly related with mortality in PAD patients. The CHA(2)DS(2)VASc score may be a useful and practical scoring method to identify high-risk patients, and further future studies are needed to assess the role of CHA(2)DS(2)VASc score in PAD.

1 June 2020 in Journal of Sleep Medicine
Verified
Journal Article
Open access
PDF file
ZYZafer Yalım
Zafer Yalım
SYSümeyra Alan Yalım
Sümeyra Alan Yalım

10 March 2020 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
ZYZafer Yalım
Zafer Yalım
MDMehmet Emin Demir
Mehmet Emin Demir
SYSumeyra Alan Yalim
Sumeyra Alan Yalim
CACaglar Alp
Caglar Alp